Smoking cessation in older adults

Jeremias, Edna Thais; Chatkin, José Miguel; Chatkin, Gustavo; Seibert, J. Anthony; Martins, Maria Auxiliadora Parreiras; Wagner, Michael

doi:10.5588/ijtld.11.0312

Cited by 16 publications

(19 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus, it was not considered practical to directly compare the studies to one another. Of the 12 articles, four have sample sizes of less than 30 [29][30][31][32], while two do not present the intervention results for the age group [33,34]. Of the remaining six, five focus on NRT [23,[35][36][37][38], with one that offers patients either NRT or bupropion [39].…”

Section: Identifying Optimal Smoking Cessation Pharmacotherapy For Olmentioning

confidence: 99%

Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence

2015

View full text Add to dashboard Cite

Nearly 12% of adults 65 years and over in Europe and 9% in the USA are current cigarette smokers. Numerous studies have demonstrated tangible benefits of smoking cessation, regardless of advanced age. However, it is unclear which pharmacotherapy strategies are most effective in the elderly population. To that end, the literature on smoking cessation in older adults was reviewed with the aim of identifying the safest and most effective cessation pharmacotherapies. MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched for all articles pertaining to elderly smoking cessation strategies. Randomized controlled trials and cohort studies were included. Studies were included without regard to population or intervention, as long as results were analyzed with a group of smokers aged 60 years and above and at least one arm of the study involved a pharmacotherapy. Only 12 studies were identified that met our inclusion criteria. The limited existing literature does not allow for a definitive answer to the most effective pharmacotherapy for smoking cessation in older adult smokers. Nicotine replacement therapy (NRT) is the pharmacotherapy most studied in older adults, and the limited evidence that exists suggests that NRT is effective for smoking cessation among this population. Higher-quality studies that directly compare cessation strategies, including bupropion and varenicline, are needed in the older population in order to guide treatment decision making.

show abstract

Section: Identifying Optimal Smoking Cessation Pharmacotherapy For Olmentioning

confidence: 99%

Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence

2015

View full text Add to dashboard Cite

show abstract

“…One study found physician intensive behavioural counselling delivered alone or in combination with pharmacotherapy to be effective in promoting adult smoking cessation in Port Alegre, Brazil (Jeremias et al, 2012). Similarly, a study found brief cessation advice offered by trained counsellors to be effective in promoting adult smoking cessation in Guangzhou, China (Zhu et al, 2009).…”

Section: Effectiveness and Cost-effectiveness Of Smoking Cessation Inmentioning

confidence: 93%

“…Out of the six studies that assessed effectiveness and costeffectiveness, one study applied randomised controlled trial methodology (Ward et al, 2012), one employed an open label study (Jeremias et al, 2012), two were cohort studies (Higashi and Barendregt, 2011;Gilbert et al, 2004), one used cross-sectional data analysis (Srivastava et al, 2013), and one used systemic data collection, followup and evaluation to design a free pilot model smoking cessation clinic (Zhu et al, 2009). For the ten studies that assessed physicians' capacity, eight were cross-sectional surveys (Vanphanom et al, 2011;Zhou et al, 2010;Muller and Wehbe, 2008;Heydari et al, 2012;Merill et al, 2009;Raw et al, 2010;Panda et al, 2013;and Pine-Abata et al, 2012), one employed stratified random sampling methodology (Gong et al, 2012), and the last was a review (Li et al, 2007).…”

Section: Methodsmentioning

confidence: 99%

“…Six studies assessed the effectiveness and cost-effectiveness of different smoking cessation interventions on adult smoking population (Jeremias et al, 2012;Higashi and Barendregt, 2011;Ward et al, 2012;Gilbert et al, 2004;Srivastava, Malhotra, Harries, Lal, and Arora, 2013;and Zhu et al, 2009). Four studies explored the reach, adoption, and institutionalisation of smoking cessation interventions in LMICs (Muller and Wehbe, 2008;Heydari et al, 2012;Raw, McNeill, and Murray, 2010;Pine-Abata et al, 2012).…”

Section: Target Populationmentioning

confidence: 98%

“…Of the six studies conducted to assess the effectiveness and cost-effectiveness of cessation interventions on adult smokers, two actively recruited participants from hospitals and primary care clinics (Jeremias et al, 2012;Ward et al, 2012). One study recruited participants through mass media publicities (Zhu et al, 2009), two were simulated cohorts of smokers (Higashi and Barendregt 2011;Gilbert et al, 2004), and one was a cross-sectional analysis of the Global Adult Tobacco Survey (GATS), India (Srivastava et al, 2013).…”

Section: Recruitment and Sample Characteristicsmentioning

confidence: 99%

See 2 more Smart Citations

Current Trends and Impact of Smoking Cessation Interventions for Adult Smokers in Low and Middle Income Countries: A Systematic Literature Review

Owotomo

2014

J. Smok Cessat

View full text Add to dashboard Cite

Objective: This study aims to systematically review the existing literature on the current developments and impact of smoking cessation interventions targeted toward adult smokers in low and middle income countries (LMICs).Methods: Major databases were searched with the following selection criteria: (1) studies based on empirical findings that demonstrate the impact of smoking cessation interventions in LMICs; (2) studies conducted in or focused on LMICs; (3) studies targeted at the adult smoking population; (4) studies focused on smoking cessation component of tobacco control; (5) studies that reported on the capacity for smoking cessation intervention and current developments in LMICs; (6) published in peer review journals between 2003 and April, 2013; (7) studies written or transcribed in English.Results: A total of 23 articles (23 studies) were included in the review. Six studies assessed the effectiveness and cost-effectiveness of smoking cessation intervention types in some LMICs. Four studies explored the reach, adoption and institutionalisation of cessation interventions. Six studies assessed physicians’ capacity to provide cessation interventions, and seven studies provided insights on current developments.Conclusion: Smoking cessation interventions are not readily available and affordable in LMICs. Extensive research is needed to determine the most cost-effective and culturally appropriate smoking cessation interventions for adult smokers in LMICs.

show abstract

Proposals for Policy Development

Givel

2014

Substance Use and Older People

View full text Add to dashboard Cite

Smoking cessation in older adults

Abstract: In this real-world setting, treatment for smoking cessation led to similar abstinence rates in older and younger smokers. These results may have implications for clinical practice and smoking cessation policies for low- and middle-income countries such as Brazil.

Cited by 16 publications

References 0 publications

Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence

Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence

Current Trends and Impact of Smoking Cessation Interventions for Adult Smokers in Low and Middle Income Countries: A Systematic Literature Review

Proposals for Policy Development

Contact Info

Product

Resources

About